Literature DB >> 25766720

Retrospective Assessment of Home Ventilation to Reduce Rehospitalization in Chronic Obstructive Pulmonary Disease.

Steven Coughlin1, Wei E Liang2, Sairam Parthasarathy3.   

Abstract

BACKGROUND: Healthcare systems are attempting to reduce hospital readmissions due to chronic obstructive pulmonary disease (COPD).
METHODS: A retrospective study of a quality improvement (QI) program performed at a single center whose multifaceted intervention included nocturnal administration of advanced positive airway pressure (PAP) modality (or noninvasive positive pressure ventilation [NIPPV]) called averaged volume assured pressure support (AVAPS-AE) initiation by a respiratory therapist (RT), medication reconciliation by a pharmacist, adequate provision of oxygen, and ongoing RT-led care. In this QI program, consecutive patients who had been hospitalized twice in a single year with an acute COPD exacerbation underwent such interventions after they met specific selection criteria.
RESULTS: Three-hundred ninety-seven consecutive patients were eligible for the program because they had two or more hospitalizations in the previous year. The proportion of patients who were readmitted on two or more occasions decreased from 100% (397 of 397) in the year prior to initiation of intervention to 2.2% (9 of 397) in the following year (χ(2) = 758, p < 0.0001). Seventy patients died over the one year following initiation of the multifaceted intervention. A composite outcome of rehospitalization and death was associated with inhaled steroids (adjusted odds ratio [adjOR] of 2.13; 95% confidence interval [CI] 1.09, 4.17; p = 0.02), whereas inhaled antimuscarinics tended to be associated with less risk for rehospitalization or death (adjOR 0.56; 95% CI 0.34, 1.03; p = 0.06).
CONCLUSION: In a retrospective cohort study of a QI initiative undertaken at a single center, we have observed that a multifaceted intervention that involved initiation of nocturnal advanced PAP (NIPPV) modality, RT-led respiratory care, medication reconciliation, appropriate oxygen therapy initiation, and patient education led to significant reduction in rehospitalization.
© 2015 American Academy of Sleep Medicine.

Entities:  

Keywords:  Intermittent Positive-Pressure Ventilation; chronic obstructive pulmonary disease; hospitalization; positive airway pressure; readmission

Mesh:

Year:  2015        PMID: 25766720      PMCID: PMC4442227          DOI: 10.5664/jcsm.4780

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  36 in total

1.  Noninvasive ventilation in COPD: impact of inspiratory pressure levels on sleep quality.

Authors:  Michael Dreher; Emelie Ekkernkamp; Stephan Walterspacher; David Walker; Claudia Schmoor; Jan H Storre; Wolfram Windisch
Journal:  Chest       Date:  2011-05-12       Impact factor: 9.410

2.  Sleep complaints predict coronary artery disease mortality in males: a 12-year follow-up study of a middle-aged Swedish population.

Authors:  L Mallon; J E Broman; J Hetta
Journal:  J Intern Med       Date:  2002-03       Impact factor: 8.989

3.  Myocardial infarction and coronary death among women: psychosocial predictors from a 20-year follow-up of women in the Framingham Study.

Authors:  E D Eaker; J Pinsky; W P Castelli
Journal:  Am J Epidemiol       Date:  1992-04-15       Impact factor: 4.897

Review 4.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

5.  Persistent insomnia is associated with mortality risk.

Authors:  Sairam Parthasarathy; Monica M Vasquez; Marilyn Halonen; Richard Bootzin; Stuart F Quan; Fernando D Martinez; Stefano Guerra
Journal:  Am J Med       Date:  2014-10-16       Impact factor: 4.965

Review 6.  Chronic obstructive pulmonary disease and sleep.

Authors:  Peter C Gay
Journal:  Respir Care       Date:  2004-01       Impact factor: 2.258

7.  Sleep duration, sleep quality and cardiovascular disease mortality among the elderly: a population-based cohort study.

Authors:  Etsuji Suzuki; Takashi Yorifuji; Kazumune Ueshima; Soshi Takao; Masumi Sugiyama; Toshiki Ohta; Kazuko Ishikawa-Takata; Hiroyuki Doi
Journal:  Prev Med       Date:  2009-06-30       Impact factor: 4.018

Review 8.  Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary disease.

Authors:  Fransien M Struik; Yves Lacasse; Roger Goldstein; Huib M Kerstjens; Peter J Wijkstra
Journal:  Cochrane Database Syst Rev       Date:  2013-06-13

9.  Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.

Authors:  Mette Thomsen; Truls Sylvan Ingebrigtsen; Jacob Louis Marott; Morten Dahl; Peter Lange; Jørgen Vestbo; Børge G Nordestgaard
Journal:  JAMA       Date:  2013-06-12       Impact factor: 56.272

10.  Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD.

Authors:  Vamsi Bollu; Frank R Ernst; John Karafilidis; Krithika Rajagopalan; Scott B Robinson; Sidney S Braman
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-12-05
View more
  11 in total

1.  Positive Airway Pressure Therapies and Hospitalization in Chronic Obstructive Pulmonary Disease.

Authors:  Monica M Vasquez; Leslie A McClure; Duane L Sherrill; Sanjay R Patel; Jerry Krishnan; Stefano Guerra; Sairam Parthasarathy
Journal:  Am J Med       Date:  2017-01-13       Impact factor: 4.965

2.  Noninvasive auto-titrating ventilation (AVAPS-AE) versus average volume-assured pressure support (AVAPS) ventilation in hypercapnic respiratory failure patients.

Authors:  Gul Gursel; Avsar Zerman; Burcu Basarik; Kamil Gonderen; Muge Aydogdu; Serriyye Memmedova
Journal:  Intern Emerg Med       Date:  2018-03-06       Impact factor: 3.397

3.  CPAP Adherence and Readmission: Marker of Health or Cost-Effective Tool?

Authors:  Lucas M Donovan; Martha E Billings
Journal:  J Clin Sleep Med       Date:  2018-02-15       Impact factor: 4.062

4.  Noninvasive auto-titrating ventilation (AVAPS-AE) versus average volume-assured pressure support (AVAPS) ventilation in hypercapnic respiratory failure patients: comment.

Authors:  Fatma Yıldırım; Edoardo Piervincenzi; Güniz Meyancı Köksal; Antonio Esquinas
Journal:  Intern Emerg Med       Date:  2018-06-06       Impact factor: 3.397

5.  Sleep in hospitalized patients with chronic obstructive pulmonary disease: an observational study.

Authors:  Nancy H Stewart; Ryan W Walters; Babak Mokhlesi; Diane S Lauderdale; Vineet M Arora
Journal:  J Clin Sleep Med       Date:  2020-10-15       Impact factor: 4.062

Review 6.  Update: non-invasive ventilation in chronic obstructive pulmonary disease.

Authors:  Neeraj Mukesh Shah; Rebecca Francesca D'Cruz; Patrick B Murphy
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

Review 7.  Domiciliary noninvasive ventilation for chronic respiratory diseases.

Authors:  Vikas Marwah; Raja Dhar; Robin Choudhary; Mark Elliot
Journal:  Med J Armed Forces India       Date:  2022-09-29

Review 8.  Is positive airway pressure therapy underutilized in chronic obstructive pulmonary disease patients?

Authors:  Hrishikesh Kulkarni; Sairam Parthasarathy
Journal:  Expert Rev Respir Med       Date:  2019-02-15       Impact factor: 3.772

9.  Comprehensive and Collaborative Pharmacist Transitions of Care Service for Underserved Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Jennifer Kim; Amy Lin; Randy Absher; Tanya Makhlouf; Casey Wells
Journal:  Chronic Obstr Pulm Dis       Date:  2021-01

10.  Does testing for sleep-disordered breathing predischarge vs postdischarge result in different treatment outcomes?

Authors:  Cinthya Pena Orbea; Hussam Jenad; Lena Lea Kassab; Erik K St Louis; Eric J Olson; Gaja F Shaughnessy; Lillian T Peng; Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2021-12-01       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.